A molecular informatics and in-vitro approach to evaluate the HMG-CoA reductase inhibitory efficacy of monoterpenes, carvacrol and geraniol
Currently, statins, the β-hydroxy-β-methyl-glutaryl-CoA reductase (HMG-R) inhibitors, are widely used to lower cholesterol, nevertheless, they have several side effects. Consequently, the present study is designed to unravel the cardioprotective role of selected natural monoterpenoids (carvacrol and...
Saved in:
| Main Authors: | Sami G. Almalki, Mohammed Alsaweed, Hind Muteb Albadrani, Yaser E. Alqurashi, Mohammed A. Bazuhair, Hamzah H. Ahmed, Parvej Ahmad, Abdulaziz Alfahed, Ayoub Al Othaim, Danish Iqbal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Taibah University for Science |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16583655.2023.2297456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico approach for identification of potential tetracyclic triterpenoids from mushroom as HMG-CoA reductase inhibitor
by: Rishav Mazumder, et al.
Published: (2024-12-01) -
QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
by: Robert Ancuceanu, et al.
Published: (2024-10-01) -
Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients
by: Esmat Khaleqsefat, et al.
Published: (2025-01-01) -
EFFICACY OF HMG-CoA REDUCTASE INHIBITORS IN COVID-19 PATIENTS MORTALITY RATE: A META-ANALYSES OF RANDOMIZED CONTROL TRIALS
by: Mohammadreza Shafiei, et al.
Published: (2024-12-01) -
Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases
by: Dzyak G.V., et al.
Published: (2013-12-01)